Source: Citybizlist

Metacrine: Metacrine Announces Executive Leadership Changes

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) - Metacrine, a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal... Read MoreThe post Metacrine Announces Executive Leadership Changes appeared first on citybiz.

Read full article »

Metacrine's Competitors | Metacrine's News | Metacrine's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

1-25

President & CEO

Michael York

CEO Approval Rating

82/100

Metacrine is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of gastrointestinal and liver diseases.